Repurposing FDA-Approved Antimalarial Drugs: Mefloquine as a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy. Indian Journal of Chemistry (IJC), [S. l.], v. 64, n. 7, p. 730–745, 2025. DOI: 10.56042/ijc.v64i7.16642. Disponível em: https://or.niscpr.res.in/index.php/IJC/article/view/16642. Acesso em: 14 may. 2026.